LYMPHOID HYPERPLASIA OF INTESTINE

LYMPHOID HYPERPLASIA OF INTESTINE was reported 22 times

LYMPHOID HYPERPLASIA OF INTESTINE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Serotonin-4 Receptor Agonist [EPC] 1 0.0015
1 Anti-coagulant [EPC] 1 0.0003
2 Antifibrinolytic Agent [EPC] 1 0.0001
3 Antimetabolite Immunosuppressant [EPC] 2 0.0001
4 Provitamin D2 Compound [EPC] 2 0.0001
5 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
6 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
7 Aluminum Complex [EPC] 1 0.0000
8 Iron Chelator [EPC] 1 0.0000
9 Rifamycin Antibacterial [EPC] 1 0.0000
10 Interleukin-17A Antagonist [EPC] 1 0.0000
11 General Anesthetic [EPC] 1 0.0000
12 Muscle Relaxant [EPC] 1 0.0000
13 Glycopeptide Antibacterial [EPC] 1 0.0000
14 Nitroimidazole Antimicrobial [EPC] 1 0.0000
15 Tetracycline-class Drug [EPC] 1 0.0000
16 Integrin Receptor Antagonist [EPC] 1 0.0000
17 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
18 Interleukin-23 Antagonist [EPC] 1 0.0000
19 Antirheumatic Agent [EPC] 1 0.0000
20 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
21 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
22 Osmotic Laxative [EPC] 2 0.0000
23 Estrogen [EPC] 1 0.0000
24 RANK Ligand Inhibitor [EPC] 1 0.0000
25 Expectorant [EPC] 1 0.0000
26 Thiazide Diuretic [EPC] 1 0.0000
27 GLP-1 Receptor Agonist [EPC] 2 0.0000
28 Alkylating Drug [EPC] 1 0.0000
29 Retinoid [EPC] 1 0.0000
30 Factor Xa Inhibitor [EPC] 1 0.0000
31 Proton Pump Inhibitor [EPC] 2 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
34 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
35 Corticosteroid [EPC] 3 0.0000
36 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
37 Platelet Aggregation Inhibitor [EPC] 1 0.0000
38 Tumor Necrosis Factor Blocker [EPC] 1 0.0000